Pascal Halbherr

MSc Biochemistry, University of Bern

Leiter Manufacturing, InnoMedica Schweiz

Pascal Halbherr, elder son of Dr. Peter Halbherr and Head of Production, began working at InnoMedica in Autumn 2012. His interest in the latest research in biochemistry and his readiness to explore novel concepts led to the launch of the collaboration with Dr. Yamazaki and form the starting point of the project for the cancer drug. Along with Stéphane Gumy, he developed the GMP production at the Marly Innovation Center and adapted the production processes from pure research to industrial scales.

Pascal Halbherr graduated from the University of Bern with a Bachelor’s degree in Biochemistry and a Master’s degree in Immunology («Thromboxane A2 acts as tonic immunoregulator by preferential disruption of low-avidity CD4+ T cell-dendritic cell interactions»).